Financial reports
Current reports
8-K
Departure of Directors or Certain Officers
12 Mar 24
8-K
Termination of a Material Definitive Agreement
7 Mar 24
8-K
Ambrx Shareholders Approve Acquisition by Johnson & Johnson
6 Mar 24
8-K
Other Events
22 Feb 24
8-K
Ambrx Announces Sale to Johnson & Johnson
8 Jan 24
8-K
Departure of Directors or Certain Officers
1 Dec 23
8-K
Other Events
23 Oct 23
8-K
Other Events
16 Oct 23
Registration and prospectus
15-12G
Securities registration termination
18 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
8 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
8 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
8 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
8 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
8 Mar 24
POS AM
Prospectus update (post-effective amendment)
7 Mar 24
25-NSE/A
Exchange delisting (amended)
7 Mar 24
S-3
Shelf registration
17 Oct 23
S-8
Registration of securities for employees
12 Oct 23
Proxies
DEFA14A
Additional proxy soliciting materials
23 Feb 24
DEFA14A
Additional proxy soliciting materials
22 Feb 24
DFAN14A
Additional proxy materials by non-management
15 Feb 24
DFAN14A
Additional proxy materials by non-management
29 Jan 24
DEFM14A
Proxy related to merger
29 Jan 24
PREM14A
Preliminary proxy related to merger
19 Jan 24
DFAN14A
Additional proxy materials by non-management
9 Jan 24
DFAN14A
Additional proxy materials by non-management
8 Jan 24
DEFA14A
Additional proxy soliciting materials
8 Jan 24
Other
EFFECT
Notice of effectiveness
11 Mar 24
EFFECT
Notice of effectiveness
3 Nov 23
CORRESP
Correspondence with SEC
1 Nov 23
CORRESP
Correspondence with SEC
25 Oct 23
UPLOAD
Letter from SEC
24 Oct 23
EFFECT
Notice of effectiveness
18 Sep 23
CORRESP
Correspondence with SEC
13 Sep 23
UPLOAD
Letter from SEC
29 Aug 23
Ownership
4
Kate Hermans
7 Mar 24
4
Janet Loesberg
7 Mar 24
4
Daniel J. O'Connor
7 Mar 24
4
Stephen C. Glover
7 Mar 24
4
Andrew Aromando
7 Mar 24
4
Sonja Nelson
7 Mar 24
4
MARGARET DALESANDRO
7 Mar 24
4
PAUL V MAIER
7 Mar 24
SC 13G/A
Venrock Healthcare Capital Partners III, L.P.
14 Feb 24
SC 13G/A
D. E. SHAW & CO, L.P.
14 Feb 24